FY2016
生效日期
- 首次收录
Postprocedural ovarian failure
类别 — 请选择更具体的编码
CDC/NCHS · FY2016首次收录 · 2015-10-01
自首次收录以来无变更记录
生效日期
Postprocedural ovarian failure
类别 — 请选择更具体的编码
CDC/NCHS · FY2016| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 分类表无变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 分类表无变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 分类表无变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
同一类别的其他条目；并非可自动替换的编码。
| 编码 | 描述 | 类别：需要更具体的编码 |
|---|---|---|
| E89.0 | Postprocedural hypothyroidism | 可计费的具体编码 |
| E89.1 | Postprocedural hypoinsulinemia | 可计费的具体编码 |
| E89.2 | Postprocedural hypoparathyroidism | 可计费的具体编码 |
| E89.3 | Postprocedural hypopituitarism | 可计费的具体编码 |
| E89.5 | Postprocedural testicular hypofunction | 可计费的具体编码 |
| E89.6 | Postprocedural adrenocortical (-medullary) hypofunction | 可计费的具体编码 |
| E89.8 | Other postprocedural endocrine and metabolic complications and disorders | 类别：需要更具体的编码 |
官方名称和说明保留来源语言。 官方来源 ↗
Excludes 1 · postprocedural ovarian failure (E89.4-)
Excludes 1 · postprocedural ovarian failure (E89.4-)
Excludes 1 · menopausal and perimenopausal disorders due to artificial or premature menopause (E89.4-, E28.31-)